Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by silvarlineon Apr 24, 2013 10:45pm
128 Views
Post# 21298633

Profiteer Lacks Some Eggs Smarts

Profiteer Lacks Some Eggs Smarts

You really don't have a clue how vaccines are made, do you? 

Pull your head out of the ground Poindexter, we're not talking meals on wheels.

For your information, it takes about one egg to make one dose of vaccine which means somewhere around 100 million egg are needed to create seasonal flu vaccines.

That’s one of the major limitations of the current process. If a strain of avian flu started infrecting humans for example, there might not be enough healthy chicken sand healthy eggs to produce.

However, companies (like MBX) are exploring new approaches that would replace this step with something faster and more reliable vaccines.

Enter virusmax ... a technology that will reduce the number of eggs by at least 50% or better.

Can you comprehend the $$$ savings?  

Would a vaccine manufacturer such as Novartis (and others) be interested in using this technology (if not already?)  

As always,

Buy, hold and accumulate.

Warren

 

 

Bullboard Posts